DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Overview of European pilot study of interferon beta-Ib in primary progressive multiple sclerosis.

Author(s): Montalban X

Affiliation(s): University Hospital Vall d'Hebron, Unitat de Neuroimmunologia Clinica, Pg Val d'Hebron 119-129 (EUI-2a P.) E-08035, Barcelona, Spain. xmontalban@.vhebron.net

Publication date & source: 2004-06, Mult Scler., 10 Suppl 1:S62

Publication type: Review

This short monograph describes a trial of interferon beta-1b in patients with primary progressive multiple sclerosis (PPMS) or transitional MS. Designed as a randomized, placebo-controlled pilot, the trial randomly placed 73 eligible patients into two groups, placebo or interferon beta-1b 8 MIU given subcutaneously every other day for two years. Significant differences favouring interferon beta-1b in the MSFC score, T2 lesion volume and TI lesion volume at 24 months were observed. Further study of interferon beta-Ib therapy in PPMS patients in warranted.

Page last updated: 2006-01-31

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017